Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
March 2007
This week we attended the Florida Orthopedic Institute's "Preservation of Motion in the Spine" course for spine surgeons designed by Antonio E. Castellvi, MD. The program has become a must-attend event for surgeons interested in motion sparing techniques and has... more
Earnings BioMimetic Therapeutics announced 4Q:06 financial results, reporting a net loss of $5.3 million or $0.34 per share and beating analysts' estimates of a loss of $0.37 per share. This compares to a net loss of $9.2 million, or $5.82... more
There is much developmental focus in the orthopedic industry on creating products that treat patients earlier in the continuum of care with the goal of slowing irreversible disease progression. When earlier intervention is dramatic, it is necessary to have a... more
Last week, Cologne Germany was host to the International Dental Show (IDS). This is the world's premier dental trade show, drawing 80,000 people to the Kolnmesse, one of the world's largest convention centers, every two years. Attendees included dentists, dental... more
A proposed regulation from FDA commissioner Dr. Andrew von Eschenbach will alter the role industry advisors play on the agency's committees. The New York Times reported that if the measure is approved, advisors with more than $50,000 a year in... more
Earnings Inion announced year-end results for 2006 on Wednesday, reporting a 25% decline in revenues. 2006 sales totaled EUR 5.7 million, compared with EUR 7.6 million in 2005. R&D spending increased 17% to EUR 5.6 million from EUR 4.8 million... more
More than 40% of investigators presenting data at the 2001 and 2002 Annual Meetings of AAOS reported conflicts of interest, and a new study in this month's JBJS shows that those conflicts were associated with positive study findings. Though investigators... more
Earnings Orthovita reported 4Q:06 revenues of $13.81 million, beating analysts' estimates of $13.76 million and reflecting 38% growth compared to $9.97 million in 4Q:05. Orthovita attributed the growth to increased U.S. sales of VITOSS® FOAM and VITAGEL®. OrthoLogic announced 2006... more
Medtronic announced yesterday that they received FDA approval to market INFUSE for oral maxillofacial and dental regenerative bone grafting procedures. This news follows the FDA Dental Products Advisory Panel recommendation for approval last fall. INFUSE has already been FDA approved... more
Most scientists, says a recent article in the Cleveland Plain Dealer, don't know how to create a product or a business to produce it. Technology transfers can help, and one particularly active program is based in the Cleveland Clinic. To... more
NEW YORK, New York, VANCOUVER, Canada, and DUBLIN, California, March 12, 2007 /PRNewswire/ -- HealthpointCapital, LLC ("HealthpointCapital") announced today the acquisition of MicroDental Laboratories, Inc. ("MicroDental" or "Micro") by its portfolio company, DTI Dental Technologies, Inc. ("DTI"). MicroDental Laboratories is... more
Smith & Nephew announced today that it is acquiring Plus Orthopedics for $889 million, including the assumption of approximately $190 million in debt. Plus Orthopedics reported revenues of $300 million and EBIT of $36 million in 2006. This purchase price... more
Earnings Orthofix International N.V. announced 4Q:06 revenue of $116.1 million, an increase of 45% over 4Q:05 and just missing estimates of $116.6 million. $28.1 million of 4Q:06's revenue can be attributed to the September 2006 acquisition of Blackstone Medical, Inc.... more
Straumann, the second largest dental implant company, has been on our radar a few times this month. First, Straumann is getting press for stating its interest in buying the not-yet-for-sale Biomet 3i. 3i would give it needed scale and management... more
Today's Wall Street Journal features an article on growth in the orthopedic market. Journalist Karen Richardson indicates that innovative, long-lasting and high-margin products are driving investment opportunities. An aging population and increased life expectancy bode well for manufacturers like Stryker... more
Following a handful of scandals, donated human tissue has shouldered a reputation for being unsafe and unreliable. However, new data demonstrates one company's efforts to process sterile and high-performance allografts. At a sports medicine conference last fall, Dr. Fred Cushner... more
Earnings Biologics LifeCell reported 4Q:06 product revenues of $39.3 million, an increase of 45% over $27.0 million in 4Q:05, but missed analysts' estimates of $39.5 million. The growth was attributed to increased demand for the Company's AlloDerm® Regenerative Tissue Matrix.... more
Complete Archive
|
